Karina Hansen
NOVARTIS
Karina Hansen is listed as NOVARTIS. Karina spoke at ISPOR Europe 2026 in November 2026 (speaker, “From Subject-Matter Brilliance to Real Impact”). Karina is scheduled to speak at ISPOR Europe 2026 on 10 November 2026.
Compiled from published conference agendas; not yet confirmed by Karina. Is this you? Claim this profile.
About
Head of HEOR &HTA, International at Novartis since 2024. 25 years of global and international experience within the Pharmaceutical Industry in senior management roles within HEOR, HTA, OR/RWE and Access at AbbVie, Allergan, and Lundbeck, building and developing high performing teams and individuals. PhD in Public Health & Health Economics from Paris XI, France. MSc in Economics, Copenhagen University, Denmark.
Upcoming
ISPOR Europe 2026 8 November 2026 – 11 November 2026
- Parallel Joint Scientific Consultations under the EU HTA Regulation: What Have We Learned from the First Procedures? Speaker · 10 November 2026
Sessions at 1 conference
ISPOR Europe 2026 8 November 2026 – 11 November 2026
- From Subject-Matter Brilliance to Real Impact Speaker · 9 November 2026